WST Earnings
Latest Revenue872.3M
Latest Net Income154.0M
| Period | EPS | Revenue | Net Income | Rev YoY | EPS YoY |
|---|
| Q2 2026 | $2.17 | 872.3M | 154.0M | +13.8% | +19.2% |
| Q1 2026 | $1.93 | 844.9M | 138.8M | +21.0% | +55.6% |
| Q4 2025 | $1.83 | 805.0M | 132.1M | +7.5% | +2.2% |
| Q3 2025 | $1.94 | 804.6M | 140.0M | +7.7% | +3.7% |
| Q2 2025 | $1.82 | 766.5M | 131.8M | +9.2% | +19.7% |
| Q1 2025 | $1.24 | 698.0M | 89.8M | +0.4% | -21.0% |
| Q4 2024 | $1.79 | 748.8M | 130.1M | +2.3% | -3.2% |
| Q3 2024 | $1.87 | 746.9M | 136.0M | -0.1% | -13.8% |
| Q2 2024 | $1.52 | 702.1M | 111.3M | — | — |
| Q1 2024 | $1.57 | 695.4M | 115.3M | — | — |
| Q4 2023 | $1.85 | 732.0M | 137.0M | — | — |
| Q3 2023 | $2.17 | 747.4M | 161.3M | — | — |
West Pharmaceutical Services (WST) — Earnings